IFM Investors Pty Ltd increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 79.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,385 shares of the company’s stock after buying an additional 7,718 shares during the period. IFM Investors Pty Ltd’s holdings in Henry Schein were worth $1,104,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in HSIC. Enterprise Financial Services Corp lifted its position in shares of Henry Schein by 101.3% during the 3rd quarter. Enterprise Financial Services Corp now owns 483 shares of the company’s stock valued at $31,000 after buying an additional 243 shares in the last quarter. Cullen Frost Bankers Inc. purchased a new position in Henry Schein in the 2nd quarter valued at $36,000. Ibex Wealth Advisors purchased a new position in Henry Schein in the 2nd quarter valued at $40,000. Meeder Asset Management Inc. purchased a new position in Henry Schein in the 2nd quarter valued at $59,000. Finally, Rational Advisors LLC lifted its holdings in Henry Schein by 24.9% in the 2nd quarter. Rational Advisors LLC now owns 903 shares of the company’s stock valued at $63,000 after purchasing an additional 180 shares in the last quarter.
Shares of HSIC traded up $0.17 during midday trading on Friday, reaching $68.91. The company had a trading volume of 905,200 shares, compared to its average volume of 1,554,308. The firm has a 50 day simple moving average of $63.16 and a 200-day simple moving average of $65.35. The company has a quick ratio of 0.95, a current ratio of 1.63 and a debt-to-equity ratio of 0.30. The stock has a market cap of $10.04 billion, a PE ratio of 16.69, a price-to-earnings-growth ratio of 2.62 and a beta of 0.85. Henry Schein, Inc. has a 1-year low of $56.58 and a 1-year high of $72.81.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.52 billion. Henry Schein had a return on equity of 15.93% and a net margin of 4.66%. The business’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.03 EPS. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 3.45 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has initiated a stock repurchase plan on Thursday, October 31st that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to buy up to 4.3% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.
A number of research analysts have weighed in on HSIC shares. Barrington Research restated a “buy” rating and issued a $75.00 price objective on shares of Henry Schein in a report on Wednesday. TheStreet upgraded Henry Schein from a “c+” rating to a “b” rating in a report on Monday, October 14th. Cleveland Research restated a “hold” rating on shares of Henry Schein in a report on Friday, November 1st. William Blair lowered Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 7th. Finally, BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Thursday, September 26th. Six investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $73.50.
In other news, Vice Chairman James P. Breslawski sold 6,856 shares of Henry Schein stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $66.96, for a total value of $459,077.76. Following the completion of the transaction, the insider now owns 242,190 shares in the company, valued at approximately $16,217,042.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stanley M. Bergman sold 90,000 shares of Henry Schein stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $67.51, for a total value of $6,075,900.00. Following the completion of the transaction, the chief executive officer now owns 344,554 shares of the company’s stock, valued at approximately $23,260,840.54. The disclosure for this sale can be found here. Insiders sold a total of 123,655 shares of company stock valued at $8,373,585 in the last quarter. Company insiders own 1.06% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Story: Penny Stocks
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.